Loading...
A cell-based drug delivery platform for treating central nervous system inflammation
Mesenchymal stem cells (MSCs) are promising candidates for the development of cell-based drug delivery systems for autoimmune inflammatory diseases, such as multiple sclerosis (MS). Here, we investigated the effect of Ro-31-8425, an ATP-competitive kinase inhibitor, on the therapeutic properties of...
Na minha lista:
| Udgivet i: | J Mol Med (Berl) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292974/ https://ncbi.nlm.nih.gov/pubmed/33398468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-020-02003-9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|